- $6.18m
- $18.57m
- $0.12m
Brief: Ainos On Dec 30 2025, Enters Distribution Agreement With Trusval Technology
Brief: Ainos Inc Receives IRB Approval From National Taiwan University Hospital For Hiv-Oral Warts Clinical Trial
Brief: Ainos Announces Plan to Initiate Taiwan Clinical Study of VELDONA for Treating Sjögren's Syndrome
Brief: Ainos Secures Taiwan Invention Patent And Advances Global Patent Protection For Veldona
Brief: Ainos Says Robust Financial Runway For Over 12 Months Following Prepayment Of A Senior Secured Convertible Note
Brief: Ainos Inc Files For Mixed Shelf Of Up To $200 Million – SEC Filing
Brief: Ase Technology Holding Reports 27.4% Stake In Ainos As Of May 3 - SEC Filing
Brief: Ainos Inc Files Prospectus Relates To Resale Of Up To 4.43 Mln Shares Of Common Stock
Brief: Ainos Inc Appointed Christopher Hsin-Liang Lee As CFO On Mar 15
Brief: Ainos CFO Meng-Lin Sung Steps Down
U.S. STOCKS ON THE MOVE-Boeing, Equitrans Midstream, Crypto-linked stocks
Brief: Ainos Inc Files Prospectus Relates To Resale Up To 2,040,000 Shares Of Common Stock
Brief: Ainos On June 30 Requested That Nasdaq Grant Co Extended Compliance Period Of 180 Additional Calendar Days
Brief: Ainos Inc - On May 16, Hui-Lan (Celia) Wu Retired As CFO Of Co
Brief: Ainos Inc Receives Notice Of Delisting From Nasdaq
Brief: Ainos Publishes Preclinical Data On VELDONA Formulation's Potential
Brief: Ainos Reports Unaudited Third Quarter Financial Results
Brief: Five New Drug Candidates Show Promise As Ainos Pursues Licensing Partners Of Its Low-Dose Oral Interferon Formulation
U.S. STOCKS ON THE MOVE-Twitter, Ainos, Miniso